GreenLight Biosciences, Inc., announced today the completion of its $18 million Series D round of financing, led by Fall Line Capital. S2G Ventures, Lewis and Clark Ventures, and Macro Capital Investments participated in the round. GreenLight Biosciences has developed a unique cell-free bioprocessing platform capable of